Abstract

Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures

Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE

Issue: Jul/Aug 2016 - Volume 20, Number 4

Page(s): 328-332

Download in electronic PDF format for $75
  • Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Page 1
  • Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Page 2
  • Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Page 3
  • Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Page 4
  • Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Page 5

Abstract

Parenteral beta-blocker therapy via continuous infusion has shown promising results for improved outcomes for patients with septic shock. As patients with septic shock may require multiple intravenous medications, compatibility is necessary to co-infuse these medications through a y-site connector. The purpose of this study was to examine the physical compatibility of select intravenous drugs used for patients with septic shock combined with various intravenous beta-blockers including esmolol, labetalol, and metoprolol through a simulated y-site infusion. The tested drugs included albumin, levothyroxine, acetaminophen, esomeprazole, doripenem, epinephrine, ibuprofen, norepinephrine, levofloxacin, cefepime, ciprofloxacin, meropenem, cisatracurium, and hydrocortisone. Equal volumes of normal saline, esmolol, labetalol, and metoprolol were combined with each test drug at maximum or commercially available concentrations as appropriate used clinically in intensive care units.The samples were examined visually against a white and black background andalso using turbidimetric measurements to determine physical compatibility.Beginning immediately after mixing, observations and analyses were taken over a one-hour period at 15-minute intervals. Each test was performed in triplicate. Many of the test drugs demonstrated visual and/or turbidimetric physical compatibility when combined with esmolol, labetalol, or metoprolol during a simulated y-site infusion. Albumin, cefepime, and hydrocortisone demonstrated physical incompatibility when combined with labetalol and should not be co-infused with labetalol. Esomeprazole and ibuprofen demonstrated physical incompatibility when combined with esmolol and labetalol and should not be co-infused with either beta-blocker. Esmolol and ciprofloxacin mixtures exhibited a statistically significant difference from control solutions and should not be co-infused.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2016
Pg. 328-332
Jul/Aug 2002
Pg. 311-315
Nov/Dec 2007
Pg. 520-524
Mar/Apr 2008
Pg. 156-160
Jan/Feb 2021
Pg. 52-61
Mar/Apr 2008
Pg. 170-173
May/Jun 2008
Pg. 276-278
Jan/Feb 2001
Pg. 69-73
May/Jun 2006
Pg. 230-233
Mar/Apr 2019
Pg. 163-166
May/Jun 2020
Pg. 194-197
Mar/Apr 2025
Pg. 121
Author(s):
Jan/Feb 2009
Pg. 78-80
Sep/Oct 2013
Pg. 436-438
Jul/Aug 2008
Pg. 368-371
May/Jun 2016
Pg. 236-238
Jul/Aug 2018
Pg. 335-339
May/Jun 2020
Pg. 238-241
May/Jun 1999
Pg. 241-244
May/Jun 2002
Pg. 230-233